In this study, we demonstrate for the first time in AD an anti-apoptotic role of IGFBP3 that protects brain cells from toxic Aβ1–42 as well as IGFBP3 modification by DNA methylation-dependent regulation. Here, IGFBP3 is linked to Alzheimer disease.